JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 56.20
-1.10 (-1.92%)
At close: Dec 16, 2025
JD Health International Market Cap
JD Health International has a market cap or net worth of 183.44 billion as of December 16, 2025. Its market cap has increased by 110.08% in one year.
Market Cap
183.44B
Enterprise Value
129.89B
Revenue
71.34B
Ranking
n/a
PE Ratio
35.32
Stock Price
56.20
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 183.44B, a decrease of -46.67%. That is a compound annual growth rate of -11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 183.44B | 104.10% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.82B |
| Hansoh Pharmaceutical Group Company | 240.58B |
| Innovent Biologics | 140.10B |
| WuXi Biologics | 138.21B |
| Sino Biopharmaceutical | 116.20B |
| Akeso | 107.04B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.28B |
| WuXi XDC Cayman | 86.35B |